Format

Send to

Choose Destination
J Acquir Immune Defic Syndr. 2015 May 1;69(1):e36-7. doi: 10.1097/QAI.0000000000000540.

Pharmacogenetic testing can identify patients taking atazanavir at risk for hyperbilirubinemia.

Author information

1
*HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand †Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand ‡Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand §Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
PMID:
25622064
DOI:
10.1097/QAI.0000000000000540
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center